Corteva, Inc. CTVA
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.40B | $16.91B | $17.23B | $17.45B | $15.65B | $14.22B | $13.85B | $14.29B | — | — |
| Cost of revenue | $9.17B | $9.53B | $9.92B | $10.44B | $9.22B | $8.51B | $8.57B | $9.95B | — | — |
| Gross profit | $8.23B | $7.38B | $7.31B | $7.02B | $6.43B | $5.71B | $5.27B | $4.34B | — | — |
| R&D | $1.47B | $1.40B | $1.34B | $1.22B | $1.19B | $1.14B | $1.15B | $1.35B | — | — |
| SG&A | $3.49B | $3.20B | $3.18B | $3.17B | $3.21B | $3.04B | $3.06B | $3.04B | — | — |
| Pre-tax income | $1.69B | $1.27B | $1.09B | $1.43B | $2.35B | $675.0M | -$316.0M | -$6.81B | — | — |
| Income tax | $484.0M | $412.0M | $152.0M | $210.0M | $524.0M | $81.0M | $46.0M | $31.0M | — | — |
| Net income | $1.09B | $907.0M | $735.0M | $1.15B | $1.76B | $681.0M | -$959.0M | -$5.07B | — | — |
| EPS, basic | 1.60 | 1.31 | 1.04 | 1.59 | 2.39 | 0.91 | -1.28 | -6.76 | — | — |
| EPS, diluted | 1.60 | 1.30 | 1.03 | 1.58 | 2.37 | 0.91 | -1.28 | -6.76 | — | — |
| Shares, diluted (wtd. avg.) | 681.4M | 696.0M | 711.9M | 724.5M | 741.6M | 751.2M | 749.5M | 749.4M | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $4.52B | $3.11B | $2.64B | $3.19B | $4.46B | $3.53B | $1.76B | $2.27B | — | — |
| Short-term investments | $9.0M | $63.0M | $98.0M | $124.0M | $86.0M | $269.0M | $5.0M | $5.0M | — | — |
| Receivables | $4.88B | $4.45B | $4.21B | $4.17B | $3.44B | $3.75B | $4.22B | $3.65B | — | — |
| Inventory | $5.67B | $5.43B | $6.90B | $6.81B | $5.18B | $4.88B | $5.03B | $5.31B | — | — |
| Total current assets | $17.34B | $15.10B | $16.26B | $16.80B | $15.55B | $14.77B | $13.52B | $22.97B | — | — |
| Property, plant and equipment | $4.22B | $4.10B | $4.29B | $4.25B | $4.33B | $4.40B | $4.55B | $4.54B | $4.65B | — |
| Goodwill | $10.46B | $10.41B | $10.61B | $9.96B | $10.11B | $10.27B | $10.23B | $10.19B | $14.87B | — |
| Other intangibles | $8.30B | $8.88B | $9.63B | $9.34B | $10.04B | $10.75B | $11.42B | $12.05B | — | — |
| Total assets | $42.84B | $40.83B | $43.00B | $42.62B | $42.34B | $42.65B | $42.40B | $108.68B | — | — |
| Accounts payable | $4.40B | $4.04B | $4.28B | $4.89B | $4.13B | $3.62B | $3.70B | $3.80B | — | — |
| Short-term debt | $782.0M | $500.0M | $196.0M | $0 | $1.0M | $1.0M | $1.0M | $263.0M | — | — |
| Total current liabilities | $12.12B | $10.39B | $10.41B | $10.74B | $9.56B | $8.55B | $8.24B | $13.31B | — | — |
| Retained earnings | -$67.0M | $55.0M | -$41.0M | $250.0M | $524.0M | $0 | -$425.0M | $0 | — | — |
| Total equity | $24.14B | $23.79B | $25.28B | $25.54B | $25.62B | $25.06B | $24.55B | $75.15B | $79.59B | $10.20B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.41B | $2.15B | $1.77B | $872.0M | $2.73B | $2.06B | $1.07B | $483.0M | — | — |
| Depreciation and amortisation | $1.20B | $1.23B | $1.21B | $1.22B | $1.24B | $1.18B | $1.60B | $2.79B | — | — |
| Capital expenditure | $591.0M | $597.0M | $595.0M | $605.0M | $573.0M | $475.0M | $1.16B | $1.50B | — | — |
| Investing cash flow | -$543.0M | -$589.0M | -$1.99B | -$632.0M | -$362.0M | -$674.0M | -$904.0M | -$505.0M | — | — |
| Financing cash flow | -$1.64B | -$1.20B | -$99.0M | -$1.18B | -$1.27B | $303.0M | -$2.93B | -$2.62B | — | — |
| Dividends paid | $475.0M | $458.0M | $439.0M | $418.0M | $397.0M | $388.0M | $194.0M | $0 | — | — |
| Buybacks | $1.07B | $1.01B | $756.0M | $1.00B | $950.0M | $275.0M | $25.0M | $0 | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001755672-26-000004.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $14.29B | $13.85B | $14.22B | $15.65B | $17.45B | $17.23B | $16.91B | $17.40B |
| Gross profit | — | — | $4.34B | $5.27B | $5.71B | $6.43B | $7.02B | $7.31B | $7.38B | $8.23B |
| Net income | — | — | -$5.07B | -$959.0M | $681.0M | $1.76B | $1.15B | $735.0M | $907.0M | $1.09B |
Recent filings and events
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Shareholder rights changed The terms attaching to the shares themselves have changed. Item 3.03
- Other event Item 8.01
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Regulation FD disclosure Item 7.01
- Other event Item 8.01
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Regulation FD disclosure Item 7.01
- Restructuring or exit costs A restructuring: layoffs, a plant closure, a business being wound down. Item 2.05
- Material impairment The company has written down the carrying value of an asset - often goodwill from an acquisition that did not work out. Item 2.06
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 0100
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| DMC | DEL MONTE CORP | $1.39B | 15.7x | 1.0% |
| DOLE | Dole plc | $1.27B | 25.4x | 8.2% |
| VFF | Village Farms International, Inc. | $314.9M | 9.5x | 10.2% |
| ALCO | ALICO, INC. | $275.7M | — | -5.5% |
| LMNR | Limoneira CO | $195.3M | — | -17.3% |
| LOCL | Local Bounti Corporation/DE | $22.2M | — | 26.8% |
| TULP | BLOOMIA HOLDINGS, INC. | $11.5M | — | — |
| EDBL | Edible Garden AG Inc | $1.6M | — | — |